BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Teva Pharmaceutical Industries Limited (TEVA) is Sued for Not Disclosing Executive Pay


11/14/2012 8:06:22 AM

How much compensation does Teva Pharmaceuticals pay ceo Jeremy Levin and his executive team? Only their accountants – and a few select insiders – know for sure. Why? The drugmaker claims to adhere to Israeli law, which permits companies with dual stock exchange listings to report these salaries on a group basis, rather than disclose individual sums. However, a pair of Israeli academics, who are also Teva shareholders, are challenging the practice, which the generic drugmaker adopted in 2000, and filed a lawsuit seeking class action status. In their view, Teva is failing to meet basic disclosure requirements and doing shareholders a disservice (here is the lawsuit, although it helps if you read Hebrew). “The result is inconceivable,” Sharon Hannes, a law professor at Tel Aviv University, and Ehud Kamar, who is a law professor at the University of Southern California, write in their complaint. “All US companies and companies traded in Israel give a breakdown of compensation to their senior officers on an individual basis. But Teva, followed by other Israeli dual-listed companies, conceal this information” As noted by Ha’aretz, which first reported their complaint, US law requires information about executive and director pay from domestic and foreign companies that issue securities, but with one exception: compensation can be disclosed on a group basis when laws of a home country do not require reporting on an individual basis.

Read at Pharmalot


Pharmalot
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->